Cameco (CCJ) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Strong operational performance in uranium and fuel services segments in Q3 2024, supporting a return to a tier one cost structure and improved cash flow generation.
Adjusted EBITDA for the first nine months approached $1 billion, with Q3 adjusted EBITDA up 32% to $308 million.
Board approved a dividend increase to $0.16 per share for 2024, with a plan to double to $0.24 by 2026.
Long-term contracting activity is gaining momentum, with contracts in uranium and fuel services spanning more than a decade.
Strategic Westinghouse acquisition (49% Cameco, 51% Brookfield) enhances nuclear fuel value chain exposure.
Financial highlights
Q3 2024 revenue rose 25% year-over-year to $721 million; gross profit increased 13% to $171 million.
2024 consolidated uranium production (owned/operated) outlook up to 23.1 million lbs; Key Lake/McArthur River output forecast raised to 19 million lbs.
JV Inkai production outlook reduced to 7.7 million lbs due to sulfuric acid supply timing.
Fuel services segment Q3 production up 60% year-over-year, with sales/delivery guidance of 13.5–14.5 million kgU and revenue guidance of $440–470 million.
Cash and equivalents were $197 million, with $1.3 billion in total debt and a $1.0 billion undrawn credit facility as of September 30, 2024.
Outlook and guidance
2024 uranium production outlook increased to up to 23.1 million pounds (Cameco's share), with total production up to 37 million pounds.
Expected uranium average realized price for 2024 raised to $77.80/lb, and consolidated revenue guidance increased to $3.01–$3.16 billion.
Westinghouse 2024 adjusted EBITDA guidance raised to $460–$530 million; growth guidance held at 6%-10% over the next five years.
Annual uranium deliveries expected between 32–34 million pounds remain unchanged.
Strong Q4 expected for both uranium and Westinghouse segments due to seasonality and delivery schedules.
Latest events from Cameco
- Rising nuclear demand and supply constraints set the stage for higher uranium prices and growth.CCJ
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Disciplined strategy, strong financials, and strategic investments drive growth in nuclear markets.CCJ
Investor presentation2 Mar 2026 - Record uncovered uranium demand and supply constraints are driving prices and strategic urgency.CCJ
35th BMO Global Metals, Mining & Critical Minerals Conference24 Feb 2026 - Record 2025 results, $80B US partnership, and strong 2026 uranium and EBITDA outlook.CCJ
Q4 202513 Feb 2026 - Strong results and outlook driven by nuclear demand, disciplined strategy, and robust reserves.CCJ
Q2 20242 Feb 2026 - Nuclear demand growth and supply discipline drive strong fundamentals and higher uranium prices.CCJ
29th Annual CIBC Western Institutional Investor Conference22 Jan 2026 - Strong demand, disciplined expansion, and vertical integration drive future growth opportunities.CCJ
TD Securities 9th Annual Nuclear Fuel Cycle and Next Generation Nuclear Roundtable19 Jan 2026 - Nuclear demand is rising amid supply constraints, with strategic assets poised for value creation.CCJ
Goldman Sachs Energy, CleanTech & Utilities Conference 202510 Jan 2026 - Nuclear demand is surging, supply is tight, and strategic moves position for global growth.CCJ
28th Annual CIBC Western Institutional Investor Conference8 Jan 2026